Dow Pharma Launches Polymer for Coating Barrier Membranes
Dow introduces solvent-free productivity technology for coating barrier membranes.
Dow Pharma and Food Solutions has introduced ETHOCEL HP, an ethylcellulose polymer for multi-particulate and taste masking applications. The technology, which was designed specifically for rotor coater systems, can be used to dry coat barrier membranes in shorter coating times, at higher efficiencies and without the need for solvents, the company reports. The product was introduced to the North American market at the 2015 annual meeting of the American Association of Pharmaceutical Scientists in Orlando, FL.
Trials conducted by Dow demonstrated that ETHOCEL HP offers a step improvement in barrier membrane coating efficiency, with 98-99% greater coating efficiency when compared to solvent or aqueous ethylcellulose systems. Improved coating efficiency could provide pharmaceutical companies with opportunities for raw material cost savings and an easier clean-up step, Dow reports.
ETHOCEL HP will be available for sampling in 2016.
Dow also announced the commercial availability of AFFINISOL HPMC HME, a cellulosic polymer for drug solubilization.
Source: Dow Pharma and Food Solutions
Benuvia Granted GMP Certification by Brazil National Health Surveillance Agency
March 14th 2025The certification allows Benuvia to produce pharmaceutical products for companies, either local to Brazil or international, that may be looking for compliant and high-quality production capabilities in the Brazilian pharmaceutical market.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development
March 26th 2024In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.
